WACKER at a Glance

 (XLS:) Download XLS

 

 

 

 

 

€ million

 

2017

 

20167

 

Change in %

 

 

 

 

 

 

 

1

EBITDA is EBIT before depreciation and amortization.

2

Margins are calculated based on sales.

3

EBIT is the result from continuing operations for the period before interest and other financial results, and income taxes.

4

Sum of cash and cash equivalents, noncurrent and current securities, and noncurrent and current financial liabilities.

5

Capital expenditures excluding acquisitions.

6

Sum of cash flow from operating activities (excluding changes in advance payments received) and cash flow from long-term investing activities (before securities), including additions due to finance leases.

7

Apart from statement-of-financial-position items, prior-year figures exclude Siltronic. Adjusted in accordance with IFRS 5 (Non-Current Assets Held for Sale and Discontinued Operations).

 

 

 

 

 

 

 

Results/Return

 

 

 

 

 

 

Sales

 

4,924.2

 

4,634.2

 

6.3

EBITDA1

 

1,014.1

 

955.5

 

6.1

EBITDA margin2 (%)

 

20.6

 

20.6

 

n. a.

EBIT3

 

423.7

 

337.5

 

25.5

EBIT margin2 (%)

 

8.6

 

7.3

 

n. a.

 

 

 

 

 

 

 

Financial result

 

-88.7

 

-91.1

 

-2.6

Income from continuing operations before income taxes

 

335.0

 

246.4

 

36.0

Income from continuing operations

 

250.1

 

178.1

 

40.4

Income from discontinued operations

 

634.7

 

11.2

 

>100

Net income for the year

 

884.8

 

189.3

 

>100

 

 

 

 

 

 

 

Earnings per share from continuing operations (basic/diluted) (€)

 

4.85

 

3.44

 

40.7

Earnings per share (basic/diluted) (€)

 

17.45

 

3.61

 

>100

ROCE (%)

 

7.5

 

6.4

 

n. a.

 

 

 

 

 

 

 

Financial Position/Cash Flows

 

 

 

 

 

 

Total assets

 

6,835.7

 

7,461.6

 

-8.4

Equity

 

3,169.3

 

2,593.2

 

22.2

Equity ratio (%)

 

46.4

 

34.8

 

n. a.

Financial liabilities

 

1,001.6

 

1,458.2

 

-31.3

Net financial debt4

 

454.4

 

992.5

 

-54.2

Capital expenditures (continuing operations)5

 

326.8

 

338.1

 

-3.3

Depreciation (continuing operations)

 

-590.4

 

-618.0

 

-4.5

Net cash flow (continuing operations)6

 

358.1

 

361.1

 

-0.8

 

 

 

 

 

 

 

Research and Development

 

 

 

 

 

 

Research and development expenses (continuing operations)

 

153.1

 

150.0

 

2.1

 

 

 

 

 

 

 

Employees

 

 

 

 

 

 

Personnel expenses (continuing operations)

 

1,198.0

 

1,101.2

 

8.8

Employees (December 31, number)

 

13,811

 

13,448

 

2.7

 

 

 

 

 

 

 

Vision

As an innovative chemical company, WACKER makes a vital contribution to improving the quality of life around the world. We want to continue developing and supplying solutions that meet our own expectations of adding value for our customers and shareholders, and growing sustainably.